AngioDynamics, Inc. (ANGO)
13.38
-0.28
(-2.05%)
USD |
NASDAQ |
Jun 26, 16:00
13.38
0.00 (0.00%)
After-Hours: 16:45
AngioDynamics Accounts Receivable (Quarterly) : 45.55M for Feb. 28, 2026
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2026 | 45.55M |
| November 30, 2025 | 44.43M |
| August 31, 2025 | 42.64M |
| May 31, 2025 | 42.89M |
| February 28, 2025 | 43.47M |
| November 30, 2024 | 43.16M |
| August 31, 2024 | 39.56M |
| May 31, 2024 | 43.61M |
| February 29, 2024 | 49.48M |
| November 30, 2023 | 51.60M |
| August 31, 2023 | 49.76M |
| May 31, 2023 | 52.83M |
| February 28, 2023 | 50.89M |
| November 30, 2022 | 52.85M |
| August 31, 2022 | 53.59M |
| May 31, 2022 | 52.30M |
| February 28, 2022 | 41.81M |
| November 30, 2021 | 38.20M |
| August 31, 2021 | 35.42M |
| May 31, 2021 | 35.40M |
| February 28, 2021 | 33.17M |
| November 30, 2020 | 33.60M |
| August 31, 2020 | 33.59M |
| May 31, 2020 | 31.26M |
| February 29, 2020 | 35.62M |
| Date | Value |
|---|---|
| November 30, 2019 | 33.99M |
| August 31, 2019 | 32.54M |
| May 31, 2019 | 43.58M |
| February 28, 2019 | 44.21M |
| November 30, 2018 | 43.37M |
| August 31, 2018 | 40.16M |
| May 31, 2018 | 39.40M |
| February 28, 2018 | 41.83M |
| November 30, 2017 | 42.07M |
| August 31, 2017 | 41.28M |
| May 31, 2017 | 44.52M |
| February 28, 2017 | 46.30M |
| November 30, 2016 | 50.17M |
| August 31, 2016 | 50.12M |
| May 31, 2016 | 52.87M |
| February 29, 2016 | 54.45M |
| November 30, 2015 | 53.12M |
| August 31, 2015 | 52.42M |
| May 31, 2015 | 58.43M |
| February 28, 2015 | 57.77M |
| November 30, 2014 | 58.56M |
| August 31, 2014 | 56.03M |
| May 31, 2014 | 61.97M |
| February 28, 2014 | 57.73M |
| November 30, 2013 | 48.40M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Globus Medical, Inc. | 686.43M |
| Abbott Laboratories | 8.21B |
| Alphatec Holdings, Inc. | 112.79M |
| AtriCure, Inc. | 71.31M |
| Baxter International, Inc. | 1.768B |